1-12 of 12
EH Estey
Close
Sort by
Journal Articles

Effect of interleukin-1 beta converting enzyme inhibitor on acute myelogenous leukemia progenitor proliferation

Z Estrov, RA Black, PR Sleath, D Harris, Q Van, R LaPushin, EH Estey, M Talpaz
Journal: Blood
Blood (1995) 86 (12): 4594–4602.
https://doi.org/10.1182/blood.V86.12.4594.bloodjournal86124594
Published: 1995
Journal Articles

Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesis

P Marlton, DF Claxton, P Liu, EH Estey, M Beran, M LeBeau, JR Testa, FS Collins, JD Rowley, MJ Siciliano
Journal: Blood
Blood (1995) 85 (3): 772–779.
https://doi.org/10.1182/blood.V85.3.772.bloodjournal853772
Published: 1995
Journal Articles

Detection of residual leukemic cells in patients with acute promyelocytic leukemia by the fluorescence in situ hybridization method: potential for predicting relapse

L Zhao, KS Chang, EH Estey, K Hayes, AB Deisseroth, JC Liang
Journal: Blood
Blood (1995) 85 (2): 495–499.
https://doi.org/10.1182/blood.V85.2.495.495
Published: 1995
Journal Articles

2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia

JF Seymour, R Kurzrock, EJ Freireich, EH Estey
Journal: Blood
Blood (1994) 83 (10): 2906–2911.
https://doi.org/10.1182/blood.V83.10.2906.2906
Published: 1994
Journal Articles

Use of colony-stimulating factors in the treatment of acute myeloid leukemia [editorial; comment]

EH Estey
Journal: Blood
Blood (1994) 83 (8): 2015–2019.
https://doi.org/10.1182/blood.V83.8.2015.2015
Published: 1994
Journal Articles

Expression of unusual immunophenotype combinations in acute myelogenous leukemia

CL Reading, EH Estey, YO Huh, DF Claxton, G Sanchez, LW Terstappen, MC O'Brien, S Baron, AB Deisseroth
Journal: Blood
Blood (1993) 81 (11): 3083–3090.
https://doi.org/10.1182/blood.V81.11.3083.3083
Published: 1993
Journal Articles

2-Chlorodeoxyadenosine in the treatment of multiple myeloma [letter] [see comments]

MA Dimopoulos, HM Kantarjian, EH Estey, R Alexanian
Journal: Blood
Blood (1992) 80 (6): 1626.
https://doi.org/10.1182/blood.V80.6.1626a.1626a
Published: 1992
Journal Articles

Intensive chemotherapy with mitoxantrone and high-dose cytosine arabinoside followed by granulocyte-macrophage colony-stimulating factor in the treatment of patients with acute lymphocytic leukemia

HM Kantarjian, EH Estey, S O'Brien, E Anaissie, M Beran, MB Rios, MJ Keating, J Gutterman
Journal: Blood
Blood (1992) 79 (4): 876–881.
https://doi.org/10.1182/blood.V79.4.876.876
Published: 1992
Journal Articles

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)

EH Estey, R Kurzrock, HM Kantarjian, SM O'Brien, KB McCredie, M Beran, C Koller, MJ Keating, C Hirsch-Ginsberg, YO Huh
Journal: Blood
Blood (1992) 79 (4): 882–887.
https://doi.org/10.1182/blood.V79.4.882.882
Published: 1992
Journal Articles

Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony- stimulating factor

EH Estey, D Dixon, HM Kantarjian, MJ Keating, K McCredie, GP Bodey, R Kurzrock, M Talpaz, EJ Freireich, AB Deisseroth
Journal: Blood
Blood (1990) 75 (9): 1766–1769.
https://doi.org/10.1182/blood.V75.9.1766.1766
Published: 1990
Journal Articles

Peripheral acute leukemia: high peripheral but low-marrow blast count

JD Cason, JM Trujillo, EH Estey, YO Huh, EJ Freireich, SA Stass
Journal: Blood
Blood (1989) 74 (5): 1758–1761.
https://doi.org/10.1182/blood.V74.5.1758.1758
Published: 1989
Journal Articles

Causes of initial remission induction failure in acute myelogenous leukemia

EH Estey, MJ Keating, KB McCredie, GP Bodey, EJ Freireich
Journal: Blood
Blood (1982) 60 (2): 309–315.
https://doi.org/10.1182/blood.V60.2.309.309
Published: 1982